DNA Diagnostics Market
The DNA diagnostics market consists of instruments, reagents, kits, services, and software used for the detection and evaluation of genetic disorders. The primary customers are diagnostic laboratories, hospitals, and clinics. Key growth drivers include the rising global prevalence of genetic conditions, significant advancements in genomic technology that improve testing accuracy and affordability, and increasing financial investments by healthcare firms in research and innovation.
CAGR
9.3%
Compound Annual Growth Rate
Current Value
$15.4B
Estimated 2026
Projected Value
$31.3B
By 2034